Coenzyme Q10 treatment in mitochondrial encephalomyopathies

European Neurology

Volumn 37, Issue 4, 1997, Pages 212-218

  Chen, Rou Shayn ^a   Huang, Chin Chang ^a   Chu, Nai Shin ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Chronic progressive external; CoQ10 therapy; MELAS; MERRF; Mitochondrial encephalomyopathies; Ophthalmoplegia

Indexed keywords

DRUG DERIVATIVE; LACTIC ACID; PYRUVIC ACID; UBIDECARENONE; UBIQUINONE; QUINONE DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CLASSIFICATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DAILY LIFE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; DRUG EFFECT; ENDURANCE; EXERCISE TEST; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MITOCHONDRIAL ENCEPHALOMYOPATHY; NEUROLOGIC EXAMINATION; RANDOMIZED CONTROLLED TRIAL; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG EFFICACY; ENCEPHALOMYOPATHY; EXTERNAL OPHTHALMOPLEGIA; FATIGUE; LACTATE BLOOD LEVEL; MELAS SYNDROME; MERRF SYNDROME; MUSCLE EXERCISE; MUSCLE STRENGTH; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; AGED; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HUMANS; LACTIC ACID; MALE; MIDDLE AGED; MITOCHONDRIAL ENCEPHALOMYOPATHIES; NEUROLOGIC EXAMINATION; PHYSICAL ENDURANCE; PYRUVIC ACID; UBIQUINONE;

EID: 0030612535     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000117445     Document Type: Article

References (25)

1. Morgan-Hughes J A, Hayes DJ. Clark JB. Landon DN, Swash M, Stark RJ, Rudge P: Mitochondrial encephalomyopathies: Biochemical studies in two cases revealing defects in the respiratory chain. Brain 1982;105:553-582.
2. DiMauro S, Bonilla E, Zeviani M, Nakagawa M. De Vivo DC: Mitochondrial myopathies. Ann Neurol 1985:17:521-538.
3. Fukuhara N, Tokiguchi S, Shirakawa S, Tsubaki T: Myoclonus epilepsy associated with ragged-red fibers (mitochondrial abnormalities): Disease entity or syndrome? Light and electron-microscopic studies of two cases and review of the literature. J Neurol Sci 1980;47: 117-133.
4. Pavlakis SG. Phillips PC, DiMauro S, De Vivo DC. Rowland LP: Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: A distinctive clinical syndrome associated with ragged-red fibers. Ann Neurol 1984:481-488.
5. Kearns TP, Sayre GP: Retinitis pigmentosa, external ophthalmoplegia, and complete heart block. Arch Ophthalmol 1958;60:280-289.
6. Hyman BK, Patten BM, Dosdon RF: Mitochondrial abnormalities in progressive external ophthalmoplegia. Am J Ophthalmol 1977:83: 362-371.
7. 10 in a patient with mitochondrial encephalomyopathy. J Neurol 1987;234:62-63.
8. 10 and idebenone. J Neurol Sci 1989;90:263-271.
9. 10 in Keams-Sayrc syndrome, Neurology 1985:35: 372-377.
10. 10. Neurology 1986;36:45-53.
11. 31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies. Neurology 1992;42:1203-1208.
12. Zierz S, Jahns G, Jerusalem F: Coenzyme Q in serum and muscle of 5 patients with Kearns-Sayre syndrome and 12 patients with ophthalmoplegia plus. J Neurol 1989;236:97-101.
13. 10 administration. J Neurol Neurosurg Psychiatry 1987:50:1475-1481.
14. 31P NMR study. Neurology 1989;39:399-403.
15. Abe K, Fujimura H, Nishikawa Y, Yorifuji S, Mezaki T, Hirono N, Nishitani N, Kameyama M: Marked reduction in CSF lactate and pyruvate levels after CoQ therapy in a patient with mitochondrial myopathy, encephalopathy, lactic acidoses and stroke-like episodes (MELAS). Acta Neurol Scand 1991;83:356-359.
16. Bresolin N, Doriguzzi C, Ponzetto C, Angelini C, Moroni I, Castelli E, Cossutta E, Binda A, Gallanli A, Gabellini S, Piccolo G, Martinuzzi A, Ciafaloni E, Amaudo E, Liciardello L, Carenzi A, Scarlato G: Ubidecarenone in the treatment of mitochondrial myopathies: a multicenter double-blind trial. J Neurol Sei 1990: 100:70-78
17. 10. Neurology 1988:38:892-899.
18. Chen RS, Huang CC, Lee CC. Wai YY, Hsi MS, Pang CY. Wei YH: Overlapping syndrome of MKRRF and MELAS: Molecular and neuroradiological studies. Acta Neurol Scand 1993; 87:494-498.
19. lys gene. Muscle Nerve 1994:17:52-57.
20. Leu(UUR) gene mutation in a Chinese family. J Neurol Neurosurg Psychiatry 1994; 57:586-589.
21. Huang CC, Wai YY, Chu NS, Liou CW, Pang CY. Shih KD, Wei YH: Mitochondrial encephalomyopathies: CT and MRI findings and correlations with clinical features. Eur Neurol 1995;35:199-205.
22. Okin PM, Ameisen O, Kligfield P: A modified treadmill exercise protocol for computer-assisted analysis of the ST segment/heart rate slope: Methods and reproducbility. J Electrocardiol 1986:19:311-318.
23. Fortuin NJ. Weiss JL: Exercise stress testing. Circulation 1977;56:699-712.
24. Takeda M, Ikenoya S, Yuzuriha T, Katayama K: Studies on reduced and oxidized coenzyme Q in mitochondria, microsome and plasma by high-performance liquid chromatography. Bio-chem Biophys Acta 1982;679:308-314.
25. 10 supplementation on exercise performance, VO2 max. and lipid peroxidation in trained cyclists. Int J Sport Nutr 1991;1:353-365.